Linden Thomas Advisory Services »

Catalyst Pharmaceutical Partners shares owned by Linden Thomas Advisory Services

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Linden Thomas Advisory Services from 13F filings

Historical chart of Linden Thomas Advisory Services investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Linden Thomas Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Linden Thomas Advisory Services

Quarter filed Position value Share count Share price at filing
2024-12-31 $681k 33k 20.87
2024-09-30 $535k 27k 19.88
2024-06-30 $330k 21k 15.49
2024-03-31 $267k 17k 15.94
2023-12-31 $186k 11k 16.81

More positions owned by Linden Thomas Advisory Services

NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Arista Networks Com Shs
Astera Labs (ALAB)
salesforce (CRM)
Applovin Corp Com Cl A (APP)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Netflix (NFLX)
U.S. Lime & Minerals (USLM)
Servicenow (NOW)

View all positions for Linden Thomas Advisory Services

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Dimensional Fund Advisors
Pacer Advisors
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
First Trust Advisors
Morgan Stanley
Royce & Associates
Bank of America Corporation
Northern Trust
Nuveen Asset Management

View all funds holding Catalyst Pharmaceutical Partners